ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OSUR OraSure Technologies Inc

4.30
0.00 (0.00%)
Pre Market
Last Updated: 09:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
OraSure Technologies Inc NASDAQ:OSUR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.30 4.18 4.55 0 09:00:00

OraSure to Participate in Upcoming Investor Conferences

13/11/2023 9:15pm

GlobeNewswire Inc.


OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart


From Jul 2023 to Jul 2024

Click Here for more OraSure Technologies Charts.

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the company is scheduled to participate in the following investor conferences:

  • Stephens Annual Investment Conference on Wednesday, November 15, with a Q&A session scheduled for 2 p.m. ET
  • Evercore ISI Annual HealthCONx Conference on Tuesday, November 28, with a Q&A session scheduled for 3 p.m. ET

Live webcasts and replays of the sessions will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. The webcasts will be archived on OraSure’s website and will be available for approximately 90 days.

About OraSure Technologies

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information through effortless tests, collection kits, and services. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass tools, services, and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, commercial entities, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Investor Contact:Media Contact:
Jason PlagmanAmy Koch
VP, Investor RelationsDirector, Corporate Communications
investorinfo@orasure.commedia@orasure.com
  

1 Year OraSure Technologies Chart

1 Year OraSure Technologies Chart

1 Month OraSure Technologies Chart

1 Month OraSure Technologies Chart